These flavonoid metabolites exert estrogen-like effects and can ameliorate postmenopausal osteoporosis by modulating estrogen receptor (ER)-mediated signaling pathways (Messina, 2016; Lambert and Jeppesen, 2018; Xiao et al., 2018). The gene discussed is ESR1; the disease is postmenopausal osteoporosis.